GENETIC PREDISPOSITION TO PERIODONTAL DISEASES: MYTH OR REALITY?

Gingivit va parodontitni o‘z ichiga olgan parodont kasalliklari dunyo bo‘ylab og‘iz bo‘shlig‘i salomatligining eng keng tarqalgan holatlaridan biridir. Bakterial infeksiyalar asosiy sabab deb hisoblansa-da, kasallikka moyillikda genetik komponent borligini ko‘rsatuvchi dalillar ortib bormoqda. Ushbu maqolada oilaviy tadqiqotlar, egizaklar ustidagi tadqiqotlar, genom bo‘ylab assotsiatsiya tadqiqotlari (GWAS) va epigenetik ta‘sirlarning har tomonlama tahlili orqali parodont kasalliklarida genetik moyillikning o‘rni o‘rganiladi. Natijalar shuni ko‘rsatadiki, genetika ma‘lum rol o‘ynasa-da, atrof-muhit va xulq-atvor omillari kasallikning namoyon bo‘lishini sezilarli darajada o‘zgartiradi. Shuningdek, genetik tadqiqotlarning parodontni shaxsiylashtirilgan davolash uchun ahamiyati ham muhokama qilinadi.

GENETIC PREDISPOSITION TO PERIODONTAL DISEASES: MYTH OR REALITY? Yusupjanova Nigora Davrbek qizi assistant at Central Asian Medical University in Fergana https://doi.org/10.5281/zenodo.15133668 Abstract: Periodontal diseases, including gingivitis and periodontitis, are among the most prevalent oral health conditions worldwide. While bacterial infections are considered the primary cause, increasing evidence suggests a genetic component in disease susceptibility. This article explores the role of genetic predisposition in periodontal diseases through a comprehensive analysis of family-based studies, twin studies, genome-wide association studies (GWAS), and epigenetic influences. The findings highlight that while genetics play a role, environmental and behavioral factors significantly modulate disease expression. The implications of genetic research for personalized periodontal treatment are also discussed. Keywords: Periodontal diseases, genetic predisposition, GWAS, periodontitis, hereditary factors.

ГЕНЕТИЧЕСКАЯ ПРЕДРАСПОЛОЖЕННОСТЬ К ЗАБОЛЕВАНИЯМ ПАРОДОНТА: МИФ ИЛИ РЕАЛЬНОСТЬ? Аннотация: Заболевания пародонта, включая гингивит и пародонтит, являются одними из самых распространенных заболеваний полости рта во всем мире. Хотя бактериальные инфекции считаются основной причиной, все больше данных свидетельствуют о генетическом компоненте восприимчивости к заболеванию. В этой статье рассматривается роль генетической предрасположенности к заболеваниям пародонта с помощью всестороннего анализа семейных исследований, исследований близнецов, исследований ассоциаций по всему геному (GWAS) и эпигенетических влияний. Результаты подчеркивают, что, хотя генетика играет определенную роль, экологические и поведенческие факторы значительно модулируют проявление заболевания. Также обсуждаются последствия генетических исследований для персонализированного лечения пародонта. Ключевые слова: заболевания пародонта, генетическая предрасположенность, GWAS, пародонтит, наследственные факторы.

INTRODUCTION Periodontal diseases affect the supporting structures of the teeth and are a major cause of tooth loss worldwide. These diseases, which include gingivitis and periodontitis, are primarily initiated by microbial biofilms that trigger an immune-inflammatory response. While bacterial accumulation is a key factor, individual variability in disease progression and severity suggests that genetic predisposition plays a significant role. Recent advances in genomics have highlighted the influence of host genetic factors on immune response, tissue integrity, and susceptibility to inflammation. Studies on genetic polymorphisms, epigenetic modifications, and gene-environment interactions provide compelling evidence that certain individuals may have a higher risk of developing periodontal diseases. This article examines whether genetic predisposition is a definitive reality or an overestimated concept by analyzing existing research on hereditary influences, genome-wide association studies (GWAS), and environmental contributions to periodontal disease. Understanding these factors can help improve early diagnosis, prevention strategies, and

personalized treatment approaches in periodontology. Although microbial plaque is the primary etiological factor, individual variability in disease progression suggests a genetic component. This article examines whether genetic predisposition is a definitive reality or an overestimated concept by analyzing existing research and evaluating the interplay between genetic and environmental factors. MATERIALS AND METHODS Study Design and Data Collection: This article is based on a comprehensive review of existing literature on the genetic predisposition to periodontal diseases. The research methodology involved a systematic search of peer-reviewed articles, meta-analyses, and genome-wide association studies (GWAS) published in reputable scientific databases, including PubMed, Scopus, and Web of Science. The search strategy included keywords such as "periodontal diseases," "genetic predisposition," "GWAS," "epigenetics," and "hereditary factors." Studies were selected based on their relevance to the genetic and epigenetic mechanisms underlying periodontal diseases, with a focus on family-based studies, twin studies, and candidate gene analyses. Inclusion and Exclusion Criteria: Articles were included if they provided insights into the genetic or epigenetic factors associated with periodontal diseases, including gingivitis and periodontitis. Studies that focused solely on environmental or behavioral factors without addressing genetic influences were excluded. Additionally, only studies published in English and conducted on human populations were considered. Data Analysis: The selected studies were analyzed to identify common genetic markers, epigenetic modifications, and gene-environment interactions associated with periodontal diseases. Data from family and twin studies were used to estimate heritability, while GWAS and candidate gene studies were reviewed to identify specific genetic polymorphisms linked to disease susceptibility. Epigenetic studies were evaluated to understand the role of DNA methylation, histone modifications, and microRNAs in periodontal disease pathogenesis. Ethical Considerations: Since this study is a review of existing literature, no new human or animal subjects were involved, and thus, no ethical approval was required. All data were obtained from publicly available sources, and proper citations were provided to acknowledge the original authors. Genetic Basis of Periodontal Diseases Evidence from Family and Twin Studies Studies on families and twins provide substantial evidence of a hereditary component in periodontal diseases. Research on monozygotic (MZ) and dizygotic (DZ) twins estimates that genetic factors contribute approximately 30-50% to periodontal disease susceptibility. These findings suggest that while genetic predisposition exists, it does not act in isolation. Family-based studies have identified a higher prevalence of periodontal diseases among first-degree relatives, suggesting an inherited susceptibility. However, differentiating genetic influence from shared environmental factors, such as diet, oral hygiene habits, and socioeconomic status, remains a challenge. Studies on adopted individuals have provided further insights, showing that individuals raised in different environments still exhibit a genetic predisposition to periodontitis when they have a family history of the disease. Genome-Wide Association Studies (GWAS) and Candidate Genes: GWAS have identified multiple genes associated with periodontal disease susceptibility, including:

IL-1 gene cluster: Variants in IL-1A and IL-1B are linked to increased inflammatory responses, making individuals more susceptible to severe periodontitis. Studies have shown that IL-1 polymorphisms are particularly relevant in populations of European descent, with a significant correlation to early-onset and aggressive periodontitis. TNF-α gene: Polymorphisms contribute to immune responses and bone resorption. TNFα variants have been found to exacerbate tissue destruction by increasing the release of proinflammatory cytokines, which leads to rapid alveolar bone loss. VDR gene (Vitamin D receptor): Affects bone metabolism and periodontal tissue health. Deficiencies in vitamin D receptor activity can impair calcium absorption, weakening the structural integrity of periodontal tissues and increasing susceptibility to periodontitis. MMP genes (Matrix metalloproteinases): MMP-8 and MMP-9 are associated with extracellular matrix breakdown, an essential process in periodontal disease progression. Elevated levels of MMP-9 activity have been correlated with more severe cases of periodontitis, particularly in smokers and diabetic patients. CDKN2B-AS1 (ANRIL gene): Found in association with cardiovascular diseases and inflammatory disorders, ANRIL polymorphisms have been implicated in increased periodontal disease risk due to their role in regulating inflammatory responses. Heritability of Periodontal Disease Subtypes Chronic periodontitis: More influenced by environmental factors, chronic periodontitis tends to develop gradually and is often associated with long-term plaque accumulation and systemic conditions such as diabetes and cardiovascular diseases. Despite some genetic influence, lifestyle factors play a dominant role in its progression. Aggressive periodontitis: Shows a stronger genetic component, with heritability estimates exceeding 50%. Studies have identified rare mutations in genes regulating neutrophil function, such as FAM5C, which have been associated with aggressive periodontitis in younger patients. Additionally, aggressive periodontitis often clusters within families, further supporting the notion of a genetic predisposition. Gene-Environment Interactions in Periodontal Diseases Despite genetic associations, environmental and lifestyle factors significantly modulate disease expression. Key factors include: Smoking: Exacerbates periodontal disease risk, even in genetically predisposed individuals. Studies have shown that smokers with IL-1 polymorphisms have an even higher risk of developing severe periodontitis. Diabetes: Genetic susceptibility to inflammation increases risk in diabetic patients. Hyperglycemia leads to an exaggerated inflammatory response, which, in combination with genetic predisposition, accelerates periodontal destruction. Oral Microbiome: A dysbiotic microbiome plays a crucial role in disease progression. Specific bacterial strains, such as Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, interact with host immune responses, influencing disease severity in individuals with genetic susceptibility. Epigenetics and Periodontal Disease: Epigenetics refers to heritable changes in gene expression that do not involve alterations to the DNA sequence. In periodontal disease, epigenetic mechanisms such as DNA methylation, histone modifications, and microRNAs (miRNAs) have been implicated in inflammatory responses and tissue destruction. Unlike genetic mutations,

epigenetic modifications are dynamic and can be influenced by environmental factors, making them crucial for understanding disease progression and potential therapeutic interventions. DNA Methylation and Gene Expression: DNA methylation is a well-documented epigenetic modification affecting gene expression by adding methyl groups to cytosine residues, typically suppressing transcription. Studies have shown that methylation levels of proinflammatory cytokine genes such as TNF-α, IL-6, and IL-8 are altered in periodontitis patients. Hypomethylation of these genes leads to their overexpression, contributing to excessive inflammation and periodontal tissue breakdown. Conversely, hypermethylation of genes involved in tissue repair and bone remodeling, such as RUNX2, may hinder regenerative processes in the periodontium. Histone Modifications and Chromatin Remodeling: Histones play a crucial role in DNA packaging and gene accessibility. Modifications such as acetylation and methylation of histone proteins influence gene expression patterns in periodontal disease. Increased histone acetylation at inflammatory gene loci has been observed in gingival tissues of periodontitis patients, promoting the persistent activation of pro-inflammatory pathways. Conversely, histone deacetylases (HDACs) have been investigated as potential therapeutic targets for modulating inflammatory gene expression and restoring homeostasis in periodontal tissues. MicroRNAs (miRNAs) in Periodontal Disease MicroRNAs are small non-coding RNAs that regulate gene expression at the posttranscriptional level. Several miRNAs have been implicated in periodontal disease pathogenesis: miR-146a: Downregulates inflammatory cytokine signaling by targeting TNF-α and IL- 1β, playing a protective role in periodontal health. miR-155: Upregulated in periodontitis, contributing to exaggerated immune responses and soft tissue degradation. miR-21: Involved in apoptosis regulation and tissue remodeling, influencing both destructive and reparative processes in the periodontium. Environmental Triggers and Epigenetic Modifications Environmental factors such as smoking, diet, and bacterial infections can induce epigenetic modifications that alter periodontal disease susceptibility: Smoking: Tobacco-related toxins lead to increased DNA methylation of genes involved in immune suppression, weakening host defense mechanisms. Dietary Influence: Nutrients such as folate, vitamin D, and polyphenols impact DNA methylation patterns and may help regulate inflammatory pathways in periodontitis. Oral Microbiome: Bacterial biofilms contribute to epigenetic reprogramming of host immune cells, influencing cytokine production and tissue degradation. Future Perspectives in Epigenetic Therapy: Epigenetic modifications provide novel targets for periodontal disease treatment. Potential strategies include: DNA Methylation Inhibitors: Targeting hypermethylated genes involved in periodontal regeneration. Histone Deacetylase (HDAC) Inhibitors: Modulating inflammatory responses and preventing excessive tissue destruction. miRNA-based Therapeutics: Using synthetic miRNA mimics or inhibitors to restore balanced gene expression and promote tissue healing. The emerging field of epigenetics offers new insights into periodontal disease pathogenesis. Unlike static genetic variations, epigenetic modifications are reversible, making

them promising targets for future therapeutic interventions. Further research is needed to develop personalized epigenetic treatments that integrate environmental and genetic risk factors, ultimately improving periodontal health outcomes. Epigenetic mechanisms such as DNA methylation, histone modifications, and microRNAs influence periodontal disease development. Unlike genetic mutations, epigenetic changes are reversible and respond to environmental factors like smoking and diet. Research has identified altered methylation patterns in inflammatory genes, linking epigenetics to disease susceptibility. Challenges and Limitations in Genetic Research Several challenges hinder the establishment of genetic markers for periodontal diseases: Population heterogeneity: Genetic variations differ across ethnic groups, requiring diverse cohort studies to validate findings. Small sample sizes in GWAS: Leading to inconsistent findings, as many studies lack sufficient power to identify rare genetic variants. Epigenetic regulation: Adds complexity to hereditary predictions, as gene-environment interactions can modify disease risk over time. Clinical Implications and Future Perspectives The integration of genetic risk assessments with periodontal treatment strategies can lead to personalized dental care. Future research should focus on: Developing genetic screening tools for early risk assessment. Exploring epigenetic therapies to modify gene expression in periodontal patients. Enhancing preventive strategies tailored to genetic susceptibility. DISCUSSION Genetic Predisposition: A Complex Interplay: The findings from this review highlight that genetic predisposition to periodontal diseases is not a myth but a well-supported reality. Family and twin studies have consistently demonstrated a hereditary component, with heritability estimates ranging from 30% to 50%. However, the role of genetics is not deterministic; it interacts with environmental and behavioral factors to influence disease progression and severity. For instance, while certain genetic polymorphisms, such as those in the IL-1 and TNF-α genes, increase susceptibility to periodontitis, their impact is often modulated by external factors like smoking, diabetes, and oral hygiene practices. The Role of GWAS and Candidate Genes: Genome-wide association studies (GWAS) have been instrumental in identifying specific genetic variants associated with periodontal diseases. Polymorphisms in genes such as IL-1A, IL-1B, TNF-α, and VDR have been linked to increased inflammatory responses and bone resorption, which are key processes in periodontal disease progression. However, the heterogeneity of genetic findings across different populations underscores the complexity of periodontal disease etiology. For example, while IL- 1 polymorphisms are strongly associated with periodontitis in European populations, their significance may vary in other ethnic groups. This highlights the need for more diverse cohort studies to validate genetic markers across different populations. Epigenetics: A Dynamic Layer of Regulation: Epigenetic mechanisms, including DNA methylation, histone modifications, and microRNAs, add another layer of complexity to the genetic predisposition to periodontal diseases. Unlike static genetic mutations, epigenetic modifications are dynamic and can be influenced by environmental factors such as smoking, diet, and bacterial infections. For instance, hypomethylation of pro-inflammatory genes like TNFα and IL-6 has been observed in periodontitis patients, leading to excessive inflammation and

tissue destruction. Conversely, hypermethylation of genes involved in tissue repair, such as RUNX2, may hinder regenerative processes. These findings suggest that epigenetic modifications not only contribute to disease susceptibility but also offer potential targets for therapeutic interventions. Gene-Environment Interactions: The interplay between genetic predisposition and environmental factors is a critical aspect of periodontal disease pathogenesis. Smoking, for example, exacerbates the risk of periodontitis in genetically susceptible individuals by inducing epigenetic changes that weaken immune responses. Similarly, diabetes interacts with genetic susceptibility to inflammation, accelerating periodontal destruction. The oral microbiome also plays a crucial role, as dysbiotic bacterial communities can trigger inflammatory responses that are more severe in individuals with genetic predispositions. These interactions emphasize the importance of a holistic approach to periodontal health management, considering both genetic and environmental risk factors. Challenges and Future Directions: Despite significant advancements in genetic research, several challenges remain. Population heterogeneity, small sample sizes in GWAS, and the complexity of epigenetic regulation complicate the identification of reliable genetic markers for periodontal diseases. Future research should focus on larger, more diverse cohort studies to validate existing findings and identify new genetic and epigenetic markers. Additionally, the development of genetic screening tools and epigenetic therapies holds promise for personalized periodontal treatment. For example, DNA methylation inhibitors and histone deacetylase (HDAC) inhibitors could be used to modulate inflammatory responses and promote tissue regeneration in periodontitis patients. CONCLUSION Genetic predisposition to periodontal diseases is a well-supported concept in scientific literature, yet it does not function in isolation. While genome-wide association studies and twin research indicate a substantial hereditary component, the progression and severity of periodontal disease are significantly influenced by environmental, behavioral, and epigenetic factors. The interplay between genetic susceptibility and external triggers such as smoking, diabetes, oral microbiome composition, and stress highlights the necessity of a multifaceted approach to periodontal health management. Furthermore, advancements in epigenetics suggest that gene expression can be modified by lifestyle and therapeutic interventions, offering promising avenues for personalized periodontal treatment. Future research should aim to refine genetic screening methods, integrate epigenetic therapies, and develop predictive models incorporating genetic, environmental, and clinical data. By combining precision medicine with preventive strategies, periodontal treatment can evolve toward a more individualized and effective approach, ultimately reducing disease burden and improving patient outcomes.